MMEDF News and Press, Mind Medicine From 03/31/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips MindMed (OTCMKTS: MMEDF ) is surging in trading today after reporting full-year 2020 results and filing preliminary registration forms with the U.S. Securities and Exchange Commission yesterday. MMEDF stock is up more...

MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS PR Newswire TORONTO , March 30, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company") (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ) is pleas...

Mind Medicine (MindMed) Inc. (OTCQB: MMEDF) announced its annual 2020 financial results for the year ended December 31 , 2020. At this time the company had no revenue to report. The net and comprehensive losses were $35.1 million for the year ending December 31, 2020 . ...

Mind Medicine (MMEDF): FY Net and comprehensive loss of $35.1MTotal assets as of Dec.31, 2020 were $85.6M, including $80.1M in cash.Press Release For further details see: Mind Medicine reports FY results

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform PR Newswire Net Cash Used in Operating Activities (Total Cash Burn) ...

Mind Medicine (MMEDF) announces the addition of Robert Malenka, neuroscientist and psychiatry professor from Stanford University, to chair the company's Scientific Advisory Board.Malenka is known for his contributions to understanding of brain plasticity mechanisms, and has extensive exp...

MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board PR Newswire Dr. Robert C. Malenka is the Pritzker Professor of Psychiatry and Behavioral Sciences, Director of the Nancy Pritzker Laboratory and Deputy Di...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’m not a huge fan of penny stocks. As I always tell clients, penny stocks are trading under $1 for a reason, and that reason is usually not a good one. But, every rule has exceptions. And my exception to the penny s...

Psychedelic Penny Stocks Continue Gaining Ground Among Mainstream Investors Like any “fringe industry,” there’s plenty of hype and speculation driving momentum behind penny stocks in certain industries. Those of you who’ve been in the markets for the last few...

MindMed Announces Inclusion in FTSE Russell Indexes PR Newswire NEW YORK , March 22, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company announced that effective as of Friday March 19th, 2021 , M...